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ABSTRACT
Objective:  To  determine  the  sociodemographic,  clinical  characteristics,  and  outcomes  of  influenza  pneumonia  patients  in
tertiary care hospital, Karachi Pakistan.
Study Design: A cross-sectional study.
Place and Duration of Study: The Aga Khan University Hospital Karachi Pakistan from  January 2013 to December 2018. 
Methodology: All adult patients who were older than 18 years and suspected to have viral pneumonia were included in the
study. Data were abstracted on 105 patients and were entered on preformed proforma after reviewing the files of patients.
Results: Ninety-four (89.5%) patients were influenza positive and 15.2% (n=16) had been vaccinated. Around 92.4% (n=97),
81.9% (n=86) and 61.9% (n=65) patients had cough, fever and shortness of breath, respectively; and 63.8% (n=67), 16.2%
(n=17), and 2.9% (n=3) patients had consolidation, nodules, and cavitation, respectively. Almost 91.4% (n=96) patients were
given treatment and discharged home; however, 7.6% (n=8) died. Procalcitonin, creatinine, HCO3 , lactate, and bilirubin level
were increased in 2nd group (mortality group) after 48 hours; however, the results were only significant for HCO3 (p = 0.035).
Conclusion: Influenza pneumonia  is  very  common in  our  population and older  people  are  more likely  to  be affected by this
disease. Patients can be prevented from adverse outcomes and complications, if diagnosed and treated in time.
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INTRODUCTION
Community-acquired pneumonia (CAP)  is  a  significant  world-
wide health problem.1  Viral  pathogens such as influenza and
rhinovirus have been implicated as causes in an estimated one-
third of CAP cases.2,3 Globally, pneumonia is the most common
infectious cause of death, the fourth most common cause of
death overall, and the second leading cause of life years lost.4
There are globally 3.5 million deaths from community-acquired
pneumonia annually.5  The influenza pandemic in 2009 had a
strong effect on clinical practice, and was the leading complica-
tion of influenza virus infection.6
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Among  viral  pneumonia,  influenza  pneumonia  is  the  most
common, both in adults and paediatric age groups.7,8 Super-
added  bacterial  pneumonia  on  the  background  of  influenza
pneumonia has been an established phenomenon and is associ-
ated with worse outcomes.9
There has been a substantial rise in the incidence of influenza
pneumonia during the winter season in Pakistan.10  The high
population density, proximity to animal reservoirs, and lack of
awareness and access to influenza immunisation, has put our
population to a substantial risk of influenza pneumonia. There
has been no study done in Pakistan to delineate the clinical
course of influenza pneumonia in our population. Studies done
in other low to middle-income countries have demonstrated a
varied demographic pattern and mortality as compared to high-
-income countries.4 Hence, this study will determine in detail
the  pattern  of  disease  (influenza  pneumonia),  its  hospital
course and mortality.
The objective of this study was to determine the clinical charac-
teristics including symptoms, laboratory findings, chest imaging,
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and  mortality  in  influenza  pneumonia  patients  admitted  at  a
tertiary care hospital in Karachi.
METHODOLOGY
A cross-sectional study was conducted in the inpatient setting of
the Aga Khan University Hospital, Karachi, Pakistan by using inpa-
tient data from  January 2013 to  December 2018.
All patients’ medical records were identified through searching
the medical records with diagnosis of suspected influenza pneu-
monia,  using  consecutive  sampling  technique.  All  adult
patients’, who were older than 18 years, suspected to have viral
pneumonia  on  presentation,  and  underwent  influenza  PCR
testing after admission to confirm the status of infection, were
included. Patients who developed hospital-acquired pneumonia,
defined as lung infiltrates and symptoms of pneumonia after 48
hours of admission, had lung infiltrates clinically consistent with
cardiogenic  pulmonary  edema,  and  improved  after  diuretics
therapy, were excluded from the study.
Pneumonia was defined as any patient having a new infiltrate on
the chest X-Ray with any one of the following characteristics:
body temperature ≥38° Celsius, cough, WBC count ≥11000/dL or
<4000/dL, and need for supplemental oxygen; which must be of
less than two weeks’ duration. Patients with clinical features of
pneumonia, whose nasopharyngeal or sputum samples for H1N1
PCR were sent within 24 hours of ER presentation, were classified
as having presumed pneumonia. If PCR results were positive in
nasopharyngeal or sputum samples, then those cases were clas-
sified as confirmed influenza pneumonia.
Data  were  extracted  on  105  patients  and  were  entered  on
preformed proforma after reviewing the files. No patient iden-
tifiers  were  recorded to  protect  patients’  privacy.  Data  were
collected on patients’ demographics such as age and gender,
patients’ history of comorbid such as the presence of diabetes
mellitus, asthma, malignancy, tuberculosis, HIV and any other
comorbidity. Data were collected on patients’ symptoms along
with symptom’s duration, X-ray findings, influenza vaccination
status, clinical laboratory investigations at the time of admission
and 48 hours after admission, to ascertain the progress of the
patients. Complications were noted, such as cardiomyopathy,
pneumothorax, acute kidney injury, and any other hospital-ac-
quired  infections;  and  outcome  of  the  patient  whether  the
patient was discharged or died.
Frequencies  and proportions  were calculate  to  describe the
characteristics of the study population for the categorical vari-
ables such as gender, presence of diabetes or asthma, etc. Histo-
grams superimposed with normal curves to check the normality
of continuous variables were used. Mean and standard devia-
tions were determined for normally distributed continuous vari-
ables (age);  otherwise,  median and interquartile  (IQR) were
determined, if data was skewed. Level of significance or alpha
was kept as 5% for this study. A new parameter was calculated
and  labelled  as  difference  in  labortary  parameter  by
subtratcting value of labortary parameters at the time of admis-
sion  and  after  48  hours  of  admission.  This  was  followed by
assessing the association between difference in the laboratory
parameter  and  clinical  outcome,  i.e.  discharge  and  death.
Mann-Whitney U-test was used to compare differences in the
laboratory parameter and clinical outcome and p-value of less
than 0.05 was used a cut-off for significant results. SPSS version
23.0 was used to analyse the data.  This study was reviewed and
approved by the Ethics Review Committees of the Aga Khan
University.
RESULTS
A total of 105 patients met inclusion criteria, who were initially
admitted  as  suspected  influenza  patients.  Around  89.5%
(n=94) of all  suspected cases were later confirmed to have
influenza pneumonia. The mean age of the patients admitted to
the hospital was 54.20±18.54 years. The most common comor-
bidity was diabetes, which was found in 40.0% (n=42) patients,
while 16.2% (n=17) had asthma, 12.4% (n=13) had COPD, and
8.6% had chronic kidney disease (n=9, Table I).
Table  I:  Sociodemographic  and  clinical  characteristics  of  patients  
presenting in a tertiary care hospital in Karachi (n=105).
Age (years) Mean (SD) 54.20 (18.54)
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Table II:  Clinical profile of patients  presenting in a tertiary care hospital
in Karachi (n=105).
Clinical parameters Median (IQR)
Leucocyte counts 11.0 (7.3 – 18.0)
Neutrophils 80.0 (70.0 – 88.0)
Lymphocytes 11.0 (8.0 – 16.2)
Hemoglobin 12.3 (11.0 – 13.5)
C-Reactive protein 3.1 (2.0 – 12.4)
Sodium 134.0 (129.0 – 137.0)
Potassium 3.7 (3.2 - 4.1)
Chloride 99.0 (94.0 -105.0)
Bicarbonate 22.0 (16.2 – 25.8)
Bilirubin levels 2.0 (1.1 – 2.0)
Partial pressure of O2 62.0 (2.0– 79.0)
Partial pressure of CO2 25.0 (2.0 – 36.0)
Table III: Laboratory parameters of patients on admission and  after 48
hours of admission between two groups (n=105).
Laboratory parameter Discharge Death p-value
Leukocyte difference 2 (-0.6 – 7.1) 3.2 (0.2 – 11.4) 0.539
Neutrophil difference 10 (-1 – 66.2) -0.9 (-9.6 – 77.9) 0.700
Lymphocyte difference 5 (-3.3 – 10) 6.7 (2.7 – 11.4) 0.208
CRP difference 0 (0 – 5.3) 0 (0 - 9.9) 0.947
Procalcitonin difference 0 (-1.2 – 0) -0.05 (-1.9 – 0.12) 0.249
Creatinine 0 (-0.7 – 0.3) -0.1 (-1.6 – 0.9) 0.631
Sodium -1 (-7 – 130) -5 (-14 – 0) 0.131
HCO3 difference 0.2 (-3 – 16) -2.8 (-11.8 – 0.2) 0.035
Bilirubin 0 (0 – 0) -0.5 (-1.6 – 0.9) 0.258
Lactate 0 (0 - 0.5) 0.2 (-2.7 – 1.7) 0.994
FiO2 0 (0 – 27) 0 (0 – 37.5) 0.762
ALT 0 (0 – 20) 25 (-14 – 143.5) 0.186
pH 0 (0 – 5.4) 0.03 (-0.1 – 0.2) 0.768
Ninety-seven (92.4%) patients had cough with a mean duration
of around 4.23 ± 2.48 days. Similarly, 81.9 % (n=86) patients
had fever with a median duration of around 3.89 ± 2.4 days.
Around two-thirds of the patients (61.9%, n=65) had shortness
of breath with a median duration of 3.0 days. With respect to the
chest X-ray findings, it was found that 63.8% (n=67) patients
had consolidation, 16.2% (n=17) had nodules, 7.6% (n=8) had
ground-glass opacity, and 14.3% (n=15) had pleural effusion.
None of the influenza positive patients had any cavitation on
chest X-ray.
Table  II  shows  the  clinical  profile  of  patients  presenting  to  a
tertiary care hospital in Karachi. The data found that median hemo-
globin was 12.3 g/l (11.0 – 13.5), median C-reactive protein was
3.1 mg/dl (2.0 – 12.4), median sodium 134.0 mol/l (129.0 – 137.0),
median potassium 3.7 (3.2 - 4.1) mmol/l, median bicarbonate 22.0
mmol/l (16.2 – 25.8), mean WBC 12.8 ± 7.4, and median bilirubin
levels 2.0 mg/dl (1.1 – 2.0).
Out of influenza-positive patients, 45.7% (n=43) needed non-in-
vasive ventilation BiPAP and 19 (22% of all positive cases) of
them needed ICU admission for invasive ventilation.  Among
16% (n=15) resuscitation code was changed from full to DNR
due to comorbid and worsening conditions. However, around
13.3% (n=14) of the patients developed hemoptysis, 25.7%
(n=27) had non ST-segment elevation myocardial infarction,
11.4% (n=12) developed cardiomyopathy, 39.4% (n=37) devel-
oped acute kidney injury. A very small proportion of patients
captured nosocomial infections by methicillin-resistant staphy-
lococcus  or  carbapenem-resistant  enterobacteriaceae  and
median length of stay was 3 days. Only 14 out of 94 influenza--
positive patients had received influenza vaccination. Only 1 out
of 14 (7%), while 80 patients did not receive the vaccine, 8 out of
this group expired (10%).
Laboratory parameters were compared of the patient on admis-
sion and after 48 hours of admission were between two groups
i.e. one group who was discharged (survival group) and one
group  of  patients  who  unfortunately  could  not  survive  in
hospital  (mortality  group).  Overall,  procalcitonin,  creatinine,
HCO3, lactate and bilirubin level increased in 2nd group (mor-
tality group) after 48 hours,  however,  the results were only
significant for HCO3 with p value 0.035 (Table III).
DISCUSSION
This study found that around 89.5% patients admitted in the
hospital were diagnosed positive for influenza pneumonia and
most of those patients were older males and diabetic. Patients
older than 50 years were more likely to have influenza when
compared to their counterparts. In addition, it was also found
that less than a quarter of patients had been vaccinated for
influenza vaccine. This study also revealed that most of the
patients presented with cough, fever, and shortness of breath;
however,  very  few  had  chest  pain  of  shorter  duration.  The
majority of the patients were found to have consolidation on the
chest X-ray and very few had nodules or capitations. Almost all
patients  were  discharged  home  after  being  treated  in  the
hospital with 8% of mortality in influenza-positive patients.
This study findings are comparable with many studies conducted
in São Paulo, which found that most of the patients had nodules,
ground-glass opacities and pleural effusion on the chest X-ray.11
The same study also found that the most common symptoms
among patients were cough, fever, and shortness of breath, which
are consistent with our study findings.11
Our study findings differ  with few studies that  found a longer
length of stay and more adverse outcomes, such as mortality
among those who had pneumonia.12,13 These differences could be
due to the severity of the condition. Patients in our study were
admitted in the ward with less severe symptoms when compared
to other studies where patients were admitted in the ICU with
more severe symptoms, thus contradicting this study findings.14,15
This study has some potential caveats that need to be addressed
in the future. One of the main potential limitations of the study is
the design, which was a cross-sectional study and the authors
could not determine the temporal precedence between various
factors and outcomes. The sample size was only 105, which was
not sufficient to adequately power our study for exploring the clin-
ical and sociodemographic determinants. Lastly, this study was
not  a  follow-up  study;  therefore,  we  do  not  know  about  the
outcomes of the patients after being discharged from the hospital.
CONCLUSION
Influenza pneumonia is very common in our population and
older people are more likely to be affected by this disease. This
study demonstrated that patients can be saved from adverse
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outcomes  and  complications,  if  diagnosed  and  treated
promptly. However, the authors recommend undertaking longi-
tudinal primary epidemiological studies to determine the long
term  outcomes  among  these  patients,  and  to  explore  their
sociodemographic and clinical characteristics with the adequ-
ately powered study.
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